📣 Exciting times at AQEMIA! We're proud to echo our CEO's announcement about our €60M Series A funding. This investment is a resounding vote of confidence in our team's commitment and strategic vision, setting the stage for transformative breakthroughs in drug discovery. We are grateful to our investors and partners in this journey – Wendel, Bpifrance Large Venture, Eurazeo, Elaia – for their trust and support as we embark on this new growth phase. This funding accelerates our mission, enhancing our unique GenAI and deep physics drug discovery platform. We're set to broaden our pipeline of proprietary drug discovery projects, advancing our work across multiple therapeutic areas. This pivotal investment not only boosts our ongoing projects but also cements our place as pioneers in pharmatech. Special shoutout to Marion Birolini and Nicolas Canouï from our team, whose exceptional contributions have been crucial to our achievements! AQEMIA Maximilien Levesque Emmanuelle Martiano Rolland Victoire Laurenty Laurent Higueret Antoine Zins David Sourdive Diane Schiller Marine Choplain #funding #seriesAfunding #drugdiscovery #nextgenpharma #quantumphysics #biotech #deeptech #genAI
🎉 60 million euros series A 🎉 I am beyond excited to share that AQEMIA raised another €30M, which grows our series A to a total of €60M, to accelerate even more on our proprietary pipeline of therapeutic molecules. 🎯 Fundraising Goals: - Getting closer to the clinic — To push our proprietary, internal, drug discovery programs closer to the clinic! 3 internal projects are already being tested in the animal. The tech works amazing - we move forward. Fast. - De-multiplying internal projects — To de-multiply the number of internal projects. We will find many new drugs, not one. That's our vision since day 1. - Recruiting a Global Team incl. Execs — To bolster our dream team. 🤝 Our investors: - The new round is led by Wendel. Welcome on board, Victoire Laurenty! We are perfectly aligned with a long term, strategic goal of building a next gen, global #pharma and #biotech leader. - All historical investors also participated, especially Laurent Higueret from Bpifrance Large Venture, Antoine Zins from Eurazeo Investment Manager and David Sourdive from Elaia. 🔬 What This Means: - This fundraising to fuel our internal pipeline of drug discovery programs is a strategic milestone in our journey, 4 years only after Emmanuelle Martiano Rolland and I spin-out from Ecole normale supérieure-PSL Research University and Centre national de la recherche scientifique. - We continue to prove again and again the real-world value we bring to drug discovery with our unique technology mixing genAI and rigorous, deep physics. A concrete example? Our recently announced $140M partnership with one of top pharma company. - We are eager to put our first molecules in the clinic. - We are proud to define new ways of making drug discoveries, for the benefits of patients waiting for solutions. We believe in the immense potential of blending unique physics with GenAI and devising the right operational model to unlock its full power. 🙏 Acknowledgments: - A heartfelt thank you to our incredible Aqemia team, especially Nicolas Canouï and Marion Birolini, and to our investors. Thank you Sofia DAHOUNE for the past 4 years together. Welcome on board, David Sourdive! - Grateful for the unwavering support of our community, and ecosystem. 🚀 The Future: - As AQEMIA takes this monumental stride, we invite you to join us in this transformative journey. - Let's redefine the future of drug discovery together! 👉 Stay tuned for all the details in our press release below! #drugdiscovery #drugdesign #genAI #Quantumphysics #deeptech #biotech cc: Jean-Noël Barrot, Maïlys Ferrere, Paul-François Fournier, Nicolas Dufourcq, Sylvie Retailleau, Bruno Le Maire, Bruno Rostand, Antoine Petit, Ingrid Delval, Alain Fuchs, Clara Chappaz, Lise ALTER, Franck Mouthon cc: Antoine Izsak, Diane Schiller, Laurent Mignon, Jérôme Michiels, David Darmon, Caroline Decaux, Déborah Loye, Louisa Mesnard, Marine Choplain, Louisa Mesnard
Great news. Congrats everyone
Impressive !
Congratulations!!
President & Chief Executive Officer, Oncodesign Services
6moCongratulations Maximilen! Glad to see your perspectives to grow a promising pipeline of DD programs. All the best